Cargando…
Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
The development and progression of non-alcoholic steatohepatitis (NASH) are linked to oxidative stress, inflammation, and fibrosis of the liver. Chymase, a chymotrypsin-like enzyme produced in mast cells, has various enzymatic actions. These actions include activation of angiotensin II, matrix metal...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589185/ https://www.ncbi.nlm.nih.gov/pubmed/33066113 http://dx.doi.org/10.3390/ijms21207543 |